Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.

Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.

Item
http://www.wikidata.org/entity/Q48598406
Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.Advances in PET imaging of P-glycoprotein function at the blood-brain barrier.Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET.Synthesis and small-animal positron emission tomography evaluation of [11C]-elacridar as a radiotracer to assess the distribution of P-glycoprotein at the blood-brain barrierTariquidar-induced P-glycoprotein inhibition at the rat blood-brain barrier studied with (R)-11C-verapamil and PET.On the rate and extent of drug delivery to the brain.Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use.P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model.Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrierPeripheral and central H1 histamine receptor occupancy by levocetirizine, a non-sedating antihistamine; a time course study in the guinea pig.The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid.Effects of hepatic ischemia-reperfusion injury on the P-glycoprotein activity at the liver canalicular membrane and blood-brain barrier determined by in vivo administration of rhodamine 123 in rats.Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil.
P2860

Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.

Item
http://www.wikidata.org/entity/Q48598406
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.
@en
Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.
@nl
type
label
Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.
@en
Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.
@nl
prefLabel
Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.
@en
Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921